Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (471-480 of 692) with videos related to

Pageof 70
Sort By:
Vaccine|April 20, 2005
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenograftsDavid B Solit, Fuzhong F Zheng, Maria Drobnjak, et al.
Radiology|July 1, 1990
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancerH R Maxon, L E Schroder, S R Thomas, et al.
Headache|October 5, 2023
Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussionAnn I Scher, James S McGinley, Lyndsey R VanDam, et al.
The Journal of Pain|July 6, 2016
United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot DataMichael Von Korff, Ann I Scher, Charles Helmick, et al.
Molecular Cancer|June 8, 2007
Identification of novel androgen receptor target genes in prostate cancerUnnati Jariwala, Jennifer Prescott, Li Jia, et al.
BJU International|November 17, 2011
Locally advanced prostate cancer: a population-based study of treatment patternsWilliam T Lowrance, Elena B Elkin, David S Yee, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.
Nature|August 5, 2005
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisZhenbang Chen, Lloyd C Trotman, David Shaffer, et al.
Pageof 70

Showing results (471-480 of 692) with videos related to

Sort By:
Pageof 70
Vaccine|April 20, 2005
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenograftsDavid B Solit, Fuzhong F Zheng, Maria Drobnjak, et al.
Radiology|July 1, 1990
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancerH R Maxon, L E Schroder, S R Thomas, et al.
Headache|October 5, 2023
Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussionAnn I Scher, James S McGinley, Lyndsey R VanDam, et al.
The Journal of Pain|July 6, 2016
United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot DataMichael Von Korff, Ann I Scher, Charles Helmick, et al.
Molecular Cancer|June 8, 2007
Identification of novel androgen receptor target genes in prostate cancerUnnati Jariwala, Jennifer Prescott, Li Jia, et al.
BJU International|November 17, 2011
Locally advanced prostate cancer: a population-based study of treatment patternsWilliam T Lowrance, Elena B Elkin, David S Yee, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.
Nature|August 5, 2005
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisZhenbang Chen, Lloyd C Trotman, David Shaffer, et al.
Pageof 70